venetoclax,azacitidine,emavusertib,ibrutinib
roche,curis,abbvie,Janssen
['mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'emavusertib']
targeted therapy emavusertib shows activity in patients with mds or aml with specific mutations #eha2022 #hematology #leusm #mds
News and views from the world of clinical oncology and hematology